NGLFINE

NGL Fine-Chem Limited

IN Healthcare Drug Manufacturers - General

Latest week
10 Jul 2026
Close
3193.600098
Fair value
1884.629532
Next-week expectancy
Undecided 49.20%
Sharemaestro

NGLFINE Chart Pack

NGL Fine-Chem Limited

Exchange
NSI
Latest week
10 Jul 2026
Close
3193.600098
Fair value
1884.629532
Next-week expectancy
Undecided 49.20%
Generated
17 Jul 2026 00:40
Sector
Healthcare
Industry
Drug Manufacturers - General

Chart Summary

Over the latest 12 completed weeks ending 2026-07-10, NGLFINE rose 42.83%, moving from 2,235.90 to 3,193.60. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 71.08 and has improved across the 12-week window. Market Dynamics is 1.43 on the latest week. Next-week expectancy is undecided at 49.20% based on similar historical setup states.

Key Points

Week Ending
10 Jul 2026
Latest Close
3,193.60
12-Week Change
42.83%
Trend Signal
Active
Next-Week Expectancy
Undecided 49.20%
Signal Weeks
12 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
71.08
Market Dynamics
1.43

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
10 Jul 2026
Latest Close
3,193.60
12-Week Change
42.83%
Trend Signal
Active
Next-Week Expectancy
Undecided 49.20%
Signal Weeks
12 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
71.08
Market Dynamics
1.43

Over the latest 12 completed weeks ending 2026-07-10, NGLFINE rose 42.83%, moving from 2,235.90 to 3,193.60. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 71.08 and has improved across the 12-week window. Market Dynamics is 1.43 on the latest week. Next-week expectancy is undecided at 49.20% based on similar historical setup states.

Industry Peers

India equities in Drug Manufacturers - General

Stock Exchange Week Open High Low Close Change
RUBICON RUBICON RESEARCH LIMITED NSI 10 Jul 2026 1330.50 1439.00 1320.00 1431.40 7.58%
PFIZER Pfizer Limited NSI 10 Jul 2026 4570.00 4747.80 4503.40 4731.40 3.53%
MARKSANS Marksans Pharma Limited NSI 10 Jul 2026 264.00 281.60 257.50 272.40 3.18%
GLAXO GlaxoSmithKline Pharmaceuticals Limited NSI 10 Jul 2026 2390.20 2460.80 2370.00 2438.20 2.01%
SENORES SENORES PHARMACEUTICALS L NSI 10 Jul 2026 1389.90 1487.90 1313.60 1417.80 2.01%
KOPRAN Kopran Limited NSI 10 Jul 2026 195.99 198.00 179.93 196.82 0.42%
TTKHLTCARE TTK Healthcare Limited NSI 10 Jul 2026 923.10 942.45 880.60 920.40 -0.29%
SANOFI Sanofi India Limited NSI 10 Jul 2026 3425.00 3488.90 3340.00 3401.90 -0.67%
SANOFICONR SANOFI CONS HEALTHC IND L NSI 10 Jul 2026 4602.90 4726.00 4500.30 4566.70 -0.79%
SMSPHARMA SMS Pharmaceuticals Limited NSI 10 Jul 2026 423.30 435.00 398.25 402.70 -4.87%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.